Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells

Harun Elmasri, Cagatay Karaaslan, Yaroslav Teper, Elisa Ghelfi, MeiQian Weng, Tan Ince, Harry Kozakewich, Joyce Bischoff, Sule Cataltepe

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte- and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and infantile hemangiomas, the most common tumor of infancy and ECs. In most of these cases, FABP4 was detected in both the nucleus and cytoplasm. FABP4 mRNA and protein levels were significantly induced in cultured ECs by VEGF-A and bFGF treatment. The effect of VEGF-A on FABP4 expression was inhibited by chemical inhibition or short-hairpin (sh) RNA-mediated knockdown of VEGF-receptor-2 (R2), whereas the VEGFR1 agonists, placental growth factors 1 and 2, had no effect on FABP4 expression. Knockdown of FABP4 in ECs significantly reduced proliferation both under baseline conditions and in response to VEGF and bFGF. Thus, FABP4 emerged as a novel target of the VEGF/VEGFR2 pathway and a positive regulator of cell proliferation in ECs.

Original languageEnglish
Pages (from-to)3865-3873
Number of pages9
JournalFASEB Journal
Volume23
Issue number11
DOIs
StatePublished - Nov 5 2009
Externally publishedYes

Fingerprint

Fatty Acid-Binding Proteins
Endothelial cells
Cell proliferation
Vascular Endothelial Growth Factor A
Endothelial Cells
Cell Proliferation
Vascular Endothelial Growth Factor Receptor
Macrophages
Hemangioma
Adipocytes
Small Interfering RNA
Tumors
Veins
Cultured Cells
Intercellular Signaling Peptides and Proteins
Cytoplasm
Proteins
Homeostasis
Tissue
Kidney

Keywords

  • Angiogenesis
  • Infantile hemangioma
  • Microvessel
  • Placenta

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. / Elmasri, Harun; Karaaslan, Cagatay; Teper, Yaroslav; Ghelfi, Elisa; Weng, MeiQian; Ince, Tan; Kozakewich, Harry; Bischoff, Joyce; Cataltepe, Sule.

In: FASEB Journal, Vol. 23, No. 11, 05.11.2009, p. 3865-3873.

Research output: Contribution to journalArticle

Elmasri, H, Karaaslan, C, Teper, Y, Ghelfi, E, Weng, M, Ince, T, Kozakewich, H, Bischoff, J & Cataltepe, S 2009, 'Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells', FASEB Journal, vol. 23, no. 11, pp. 3865-3873. https://doi.org/10.1096/fj.09-134882
Elmasri, Harun ; Karaaslan, Cagatay ; Teper, Yaroslav ; Ghelfi, Elisa ; Weng, MeiQian ; Ince, Tan ; Kozakewich, Harry ; Bischoff, Joyce ; Cataltepe, Sule. / Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. In: FASEB Journal. 2009 ; Vol. 23, No. 11. pp. 3865-3873.
@article{c2b9782f1b294a41af590ae4a43b2d43,
title = "Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells",
abstract = "Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte- and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and infantile hemangiomas, the most common tumor of infancy and ECs. In most of these cases, FABP4 was detected in both the nucleus and cytoplasm. FABP4 mRNA and protein levels were significantly induced in cultured ECs by VEGF-A and bFGF treatment. The effect of VEGF-A on FABP4 expression was inhibited by chemical inhibition or short-hairpin (sh) RNA-mediated knockdown of VEGF-receptor-2 (R2), whereas the VEGFR1 agonists, placental growth factors 1 and 2, had no effect on FABP4 expression. Knockdown of FABP4 in ECs significantly reduced proliferation both under baseline conditions and in response to VEGF and bFGF. Thus, FABP4 emerged as a novel target of the VEGF/VEGFR2 pathway and a positive regulator of cell proliferation in ECs.",
keywords = "Angiogenesis, Infantile hemangioma, Microvessel, Placenta",
author = "Harun Elmasri and Cagatay Karaaslan and Yaroslav Teper and Elisa Ghelfi and MeiQian Weng and Tan Ince and Harry Kozakewich and Joyce Bischoff and Sule Cataltepe",
year = "2009",
month = "11",
day = "5",
doi = "10.1096/fj.09-134882",
language = "English",
volume = "23",
pages = "3865--3873",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "11",

}

TY - JOUR

T1 - Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells

AU - Elmasri, Harun

AU - Karaaslan, Cagatay

AU - Teper, Yaroslav

AU - Ghelfi, Elisa

AU - Weng, MeiQian

AU - Ince, Tan

AU - Kozakewich, Harry

AU - Bischoff, Joyce

AU - Cataltepe, Sule

PY - 2009/11/5

Y1 - 2009/11/5

N2 - Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte- and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and infantile hemangiomas, the most common tumor of infancy and ECs. In most of these cases, FABP4 was detected in both the nucleus and cytoplasm. FABP4 mRNA and protein levels were significantly induced in cultured ECs by VEGF-A and bFGF treatment. The effect of VEGF-A on FABP4 expression was inhibited by chemical inhibition or short-hairpin (sh) RNA-mediated knockdown of VEGF-receptor-2 (R2), whereas the VEGFR1 agonists, placental growth factors 1 and 2, had no effect on FABP4 expression. Knockdown of FABP4 in ECs significantly reduced proliferation both under baseline conditions and in response to VEGF and bFGF. Thus, FABP4 emerged as a novel target of the VEGF/VEGFR2 pathway and a positive regulator of cell proliferation in ECs.

AB - Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte- and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and infantile hemangiomas, the most common tumor of infancy and ECs. In most of these cases, FABP4 was detected in both the nucleus and cytoplasm. FABP4 mRNA and protein levels were significantly induced in cultured ECs by VEGF-A and bFGF treatment. The effect of VEGF-A on FABP4 expression was inhibited by chemical inhibition or short-hairpin (sh) RNA-mediated knockdown of VEGF-receptor-2 (R2), whereas the VEGFR1 agonists, placental growth factors 1 and 2, had no effect on FABP4 expression. Knockdown of FABP4 in ECs significantly reduced proliferation both under baseline conditions and in response to VEGF and bFGF. Thus, FABP4 emerged as a novel target of the VEGF/VEGFR2 pathway and a positive regulator of cell proliferation in ECs.

KW - Angiogenesis

KW - Infantile hemangioma

KW - Microvessel

KW - Placenta

UR - http://www.scopus.com/inward/record.url?scp=70350550302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350550302&partnerID=8YFLogxK

U2 - 10.1096/fj.09-134882

DO - 10.1096/fj.09-134882

M3 - Article

C2 - 19625659

AN - SCOPUS:70350550302

VL - 23

SP - 3865

EP - 3873

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 11

ER -